Sea Crest Wealth Management, LLC Cue Biopharma, Inc. Transaction History
Sea Crest Wealth Management, LLC
- $902 Million
- Q3 2024
A detailed history of Sea Crest Wealth Management, LLC transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Sea Crest Wealth Management, LLC holds 13,000 shares of CUE stock, worth $20,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,000
Previous 13,000
-0.0%
Holding current value
$20,540
Previous $16,000
43.75%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CUE
# of Institutions
53Shares Held
14.3MCall Options Held
14.4KPut Options Held
2.6K-
Bleichroeder LP New York, NY5MShares$7.9 Million1.28% of portfolio
-
Slate Path Capital LP New York, NY2.4MShares$3.8 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.03MShares$3.21 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$1.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA509KShares$803,9460.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $55.9M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...